fenoprofen
Trade name: nalfon
Approved
Mar 16, 1976
Fenoprofen is a propionic acid derivative with analgesic, antiinflammatory and antipyretic properties. Fenoprofen inhibits prostaglandin synthesis by decreasing the enzyme needed for biosynthesis. In patients with rheumatoid arthritis, the anti-inflammatory action of fenoprofen has been evidenced by relief of pain, increase in grip strength, and reductions in joint swelling, duration of morning stiffness, and disease activity (as assessed by both the investigator and the patient). In patients with osteoarthritis, the anti-inflammatory and analgesic effects of fenoprofen have been demonstrated by reduction in tenderness as a response to pressure and reductions in night pain, stiffness, swelling, and overall disease activity (as assessed by both the patient and the investigator). These effects have also been demonstrated by relief of pain with motion and at rest and increased range of motion in involved joints. In patients with rheumatoid arthritis and osteoarthritis, clinical studies have shown fenoprofen to be comparable to aspirin in controlling the aforementioned measures of disease activity, but mild gastrointestinal reactions (nausea, dyspepsia) and tinnitus occurred less frequently in patients treated with fenoprofen than in aspirin-treated patients. It is not known whether fenoprofen causes less peptic ulceration than does aspirin. In patients with pain, the analgesic action of fenoprofen has produced a reduction in pain intensity, an increase in pain relief, improvement in total analgesia scores, and a sustained analgesic effect. Indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. Also for the relief of mild to moderate pain. — NCATS
Clinical trial activity
0 trials · 0 clinical orgs · 19 marketing orgs
Timeline
1970s
- Mar 16, 1976
Xspire Pharma — Earliest FDA Approval
- Mar 16, 1976
Xspire Pharma — NDA Secondary Org
- Mar 16, 1976
Xspire Pharma — NDA Organization
- Mar 16, 1976
KEY THERAP — Marketing Organization
- Jun 9, 1977
Eli Lilly — NDA Secondary Org
1980s
- Apr 20, 1988
DAVA Pharmaceuticals — Marketing Organization
- May 2, 1988
Actavis — Marketing Organization
- May 2, 1988
Ani Pharmaceuticals — Marketing Organization
- Jun 8, 1988
Xspire Pharma — Marketing Organization
- Jun 13, 1988
Teva — Marketing Organization
- Jul 19, 1988
Par Pharmaceuticals — Marketing Organization
- Jul 19, 1988
Strides Pharma Science — Marketing Organization
- Aug 26, 1988
Quantum Pharmaceutical — Marketing Organization
- Oct 11, 1988
Watson Pharmaceuticals — Marketing Organization
- Oct 14, 1988
Aurobindo Pharma — Marketing Organization
- Oct 14, 1988
Rising Pharmaceuticals — Marketing Organization
1990s
- Dec 21, 1990
Sun Pharmaceuticals — Marketing Organization
2020s
- May 16, 2023
Misemer Pharmaceutical — Marketing Organization
Indications
Mechanism of action
- CyclooxygenaseINHIBITOR
Cyclooxygenase inhibitor
Approval history
- approvedPriority reviewMar 16, 1976
Chemistry & pharmacology
SMILES
CC(C(=O)O)c1cccc(Oc2ccccc2)c1- Mol. weight
- 242.27 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
- Delivery
- Oral
- Availability
- Prescription Only
Oral
Yes
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1297 ↗
- WikipediaFenoprofen ↗
- NCATSRA33EAC7KY ↗
- ChEMBLCHEMBL2103736 ↗
Also known as
- (+-)-2-(3-phenoxyphenyl)propionic acid
- (+-)-2-(3-phenoxyphenyl)propionic acid
- 2-(3-phenoxyphenyl)propionic acid
- 2-(3-phenoxyphenyl)propionic acid
- 2-(m-phenoxyphenyl)propionic acid
- 2-(m-phenoxyphenyl)propionic acid
- 3-phenoxyhydratropic acid
- 3-phenoxyhydratropic acid
- 3-phenoxyhydratropic acid
- 53858
- 69323
- alpha-methyl-3-phenoxybenzeneacetic acid
- alpha-methyl-3-phenoxybenzeneacetic acid
- alpha-(m-phenoxyphenyl)propionic acid
- alpha-(m-phenoxyphenyl)propionic acid
- dl-2-(3-phenoxyphenyl)propionic acid
- dl-2-(3-phenoxyphenyl)propionic acid
- fenoprofen
- fenoprofen
- fenoprofen
- fenoprofen
- fenoprofen
- fenoprofen
- fenoprofen
- fenoprofen
- fenoprofen
- (+/-)-fenoprofen
- (+/-)-fenoprofen
- (+/-)-fenoprofen
- fenoprofen calcium
- fenoprofen calcium
- fenoprofen calcium
- fenoprofen calcium
- fenoprofen calcium salt
- fenoprofen calcium salt dihydrate
- fénoprofène
- fénoprofène
- fenoprofeno
- fenoprofeno
- fenoprofenum
- fenoprofenum
- (+/-)-m-phenoxyhydratropic acid
- (+/-)-m-phenoxyhydratropic acid
- nalfon
- nalfon
- nalfon
- progesic
- progesic
Organizations
Marketing (23)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Actavis | For profit | MKTG | May 2, 1988 |
| Am Therap | For profit | MKTG | — |
| Ani Pharmaceuticals | For profit | MKTG | May 2, 1988 |
| Ani Pharmaceuticals | For profit | SYN | May 2, 1988 |
| Aurobindo Pharma | For profit | MKTG | Oct 14, 1988 |
| DAVA Pharmaceuticals | For profit | MKTG | Apr 20, 1988 |
| Eli Lilly | For profit | NDA2 | Jun 9, 1977 |
| Halsey | For profit | MKTG | — |
| KEY THERAP | For profit | MKTG | Mar 16, 1976 |
| Misemer Pharmaceutical | For profit | MKTG | May 16, 2023 |
| Par Pharmaceuticals | For profit | MKTG | Jul 19, 1988 |
| Quantum Pharmaceutical | For profit | MKTG | Aug 26, 1988 |
| Rising Pharmaceuticals | For profit | MKTG | Oct 14, 1988 |
| Strides Pharma Science | For profit | MKTG | Jul 19, 1988 |
| Sun Pharmaceuticals | For profit | MKTG | Dec 21, 1990 |
| Teva | For profit | SYN | Aug 29, 1988 |
| Teva | For profit | MKTG | Jun 13, 1988 |
| Upsher-Smith Laboratories | For profit | MKTG | — |
| Warner Chilcott | For profit | MKTG | — |
| Watson Pharmaceuticals | For profit | MKTG | Oct 11, 1988 |
| Xspire Pharma | For profit | NDA2 | Mar 16, 1976 |
| Xspire Pharma | For profit | NDA | Mar 16, 1976 |
| Xspire Pharma | For profit | MKTG | Jun 8, 1988 |